Global and United States Artificial Intelligence (AI) in Biotechnology Market Report & Forecast 2024-2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Software
Publisher : MRA | Format : PDF
Global and United States Artificial Intelligence (AI) in Biotechnology Market Report & Forecast 2024-2034
AI in biotech is critical for boosting invention in labs and throughout a medicine's or chemical compound's lifecycle. AI-based tools and applications aid in the development of molecule structures per the target market. Machine learning, a subset of artificial intelligence, aids in estimating combinations and permutations of different compounds to determine the best combination without the need for manual experiments in the lab. Artificial intelligence's application in biotech brings about innovations that aid predictive modeling to forecast market demand for a specific drug or chemical. AI in Biotech can also assist in the smart distribution of raw materials needed by the biotech sector via cloud computing.
Market Analysis and InsightsGlobal and United States Artificial Intelligence (AI) in Biotechnology Market
This report focuses on global and United States Artificial Intelligence (AI) in Biotechnology market, also covers the segmentation data of other regions in regional level and county level.
The global Artificial Intelligence (AI) in Biotechnology revenue was US$ 2325 million in 2023 and is forecast to a readjusted size of US$ 9367.4 million by 2033 with a CAGR of 21.5% during the review period (2023-2033).
In United States the Artificial Intelligence (AI) in Biotechnology revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Artificial Intelligence (AI) in Biotechnology include AstraZeneca, Abbott Laboratories, Amgen, Inc., Atomwise, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc and Johnson & Johnson Services, Inc., etc. The global five biggest players hold a share of % in 2023.
Global Artificial Intelligence (AI) in Biotechnology Scope and Market Size
Artificial Intelligence (AI) in Biotechnology market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Artificial Intelligence (AI) in Biotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Artificial Intelligence (AI) in Biotechnology market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
AstraZeneca
Abbott Laboratories
Amgen, Inc.
Atomwise
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc
Johnson & Johnson Services, Inc.
Pfizer, Inc.
Merck KGaA
Novo Nordisk A/S
Novartis AG
Sanofi
Segment by Type
Hardware
Software and Services
Agriculture Biotechnology
Medical Biotechnology
Animal Biotechnology
Industrial Biotechnology
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter 1Introduces Artificial Intelligence (AI) in Biotechnology definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Artificial Intelligence (AI) in Biotechnology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Artificial Intelligence (AI) in Biotechnology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence (AI) in Biotechnology revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Market Analysis and InsightsGlobal and United States Artificial Intelligence (AI) in Biotechnology Market
This report focuses on global and United States Artificial Intelligence (AI) in Biotechnology market, also covers the segmentation data of other regions in regional level and county level.
The global Artificial Intelligence (AI) in Biotechnology revenue was US$ 2325 million in 2023 and is forecast to a readjusted size of US$ 9367.4 million by 2033 with a CAGR of 21.5% during the review period (2023-2033).
In United States the Artificial Intelligence (AI) in Biotechnology revenue is expected to grow from US$ million in 2023 to US$ million by 2033, at a CAGR of % during the forecast period 2023-2033.
The global key players of Artificial Intelligence (AI) in Biotechnology include AstraZeneca, Abbott Laboratories, Amgen, Inc., Atomwise, Biogen, Bristol-Myers Squibb, F. Hoffmann-La Roche Ltd., Gilead Sciences, Inc and Johnson & Johnson Services, Inc., etc. The global five biggest players hold a share of % in 2023.
Global Artificial Intelligence (AI) in Biotechnology Scope and Market Size
Artificial Intelligence (AI) in Biotechnology market is segmented in regional and country level, by players, by Type and by Application. Companies, stakeholders, and other participants in the global Artificial Intelligence (AI) in Biotechnology market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2018-2033.
For United States market, this report focuses on the Artificial Intelligence (AI) in Biotechnology market size by players, by Type and by Application, for the period 2018-2033. The key players include the global and local players, which play important roles in United States.
By Company
AstraZeneca
Abbott Laboratories
Amgen, Inc.
Atomwise
Biogen
Bristol-Myers Squibb
F. Hoffmann-La Roche Ltd.
Gilead Sciences, Inc
Johnson & Johnson Services, Inc.
Pfizer, Inc.
Merck KGaA
Novo Nordisk A/S
Novartis AG
Sanofi
Segment by Type
Hardware
Software and Services
Segment by Application
Agriculture Biotechnology
Medical Biotechnology
Animal Biotechnology
Industrial Biotechnology
Others
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa
Chapter Introduction
Chapter 1Introduces Artificial Intelligence (AI) in Biotechnology definition, global market size, United States market size, United States percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Artificial Intelligence (AI) in Biotechnology companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger and acquisition information, etc.
Chapter 5Revenue of Artificial Intelligence (AI) in Biotechnology in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.
Chapter 6Americas by type, by application and by country revenue for each segment.
Chapter 7EMEA by type, by application and by region, revenue for each segment.
Chapter 8China by type, by application revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Artificial Intelligence (AI) in Biotechnology revenue, gross margin and recent development, etc.
Chapter 11Analyst's Viewpoints/Conclusions
Electronic and Semiconductor
Food and Beverages
Chemicals and Materials
Consumer Goods
Construction Manufacturing
Aerospace and Defence
Energy and Power
ICT Media
Banking and Finance
Automotive and Transportation
Machinery and Equipments
Pharmaceutical and Healthcare
Medical Devices